Larimar Therapeutics Inc (LRMR)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総資産 | 126.41M | 118.91M | 111.72M | 103.95M | 95.94M | 248.21M | 237.16M | 219.02M |
流動資産合計 | 120.74M | 113.46M | 106.48M | 98.48M | 90.18M | 230.95M | 231.13M | 213.26M |
現金および同等物 | 26.83M | 111.52M | 94.32M | 38.72M | 26.75M | 110.13M | 32.31M | 35.07M |
非流動資産合計 | 6.5M | 6.2M | 5.92M | 6.07M | 6.44M | 17.86M | 6.88M | 6.54M |
負債合計 | 15.5M | 12.67M | 11.79M | 11.24M | 14.22M | 17.36M | 25.76M | 20.62M |
流動負債合計 | 10.71M | 8.01M | 7.28M | 6.56M | 9.51M | 12.84M | 21.16M | 16.29M |
非流動負債合計 | 4.8M | 4.66M | 4.51M | 4.68M | 4.71M | 4.52M | 4.6M | 4.34M |
普通株 | 43k | 43k | 43k | 43k | 43k | 64k | 64k | 64k |
留保所得 | -151.61M | -158.13M | -166.5M | -175.56M | -188.55M | -203.21M | -224.84M | -240.33M |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総資産 | 131.62M | 105.51M | 121.76M | 80.73M | 104.69M | 78.67M | 126.41M | 95.94M |
流動資産合計 | 130.9M | 104.93M | 121.33M | 71.5M | 97.95M | 72.2M | 120.74M | 90.18M |
現金および同等物 | 32.35M | 40.78M | 49.33M | 27.21M | 68.15M | 70.1M | 26.83M | 26.75M |
非流動資産合計 | 121.73M | 78.22M | 93.27M | 53.62M | 89.69M | 64.41M | 110.9M | 81.72M |
負債合計 | 9.89M | 27.29M | 28.49M | 27.11M | 14.99M | 14.25M | 15.5M | 14.22M |
流動負債合計 | 9.89M | 7.29M | 13.31M | 12.19M | 8.99M | 8.85M | 10.71M | 9.51M |
非流動負債合計 | 0 | 40M | 30.37M | 23.38M | 6M | 5.41M | 4.8M | 4.71M |
総資本 | 121.73M | 78.22M | 93.27M | 53.62M | 89.69M | 64.41M | 110.9M | 81.72M |
普通株 | 27k | 27k | 37k | 37k | 15k | 18k | 43k | 43k |
留保所得 | -237.55M | -289.58M | -350.95M | -396.35M | -65.61M | -116.25M | -151.61M | -188.55M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約